vergriffen

Reducing Race Differences in Direct To Consumer Pharmaceutical - The Case for Regulation

Englisch · Fester Einband

Beschreibung

Mehr lesen










Reducing health disparities by increasing access to health information is a national health policy priority. Evidence exists that direct-to-consumer pharmaceutical advertising (DTCA) is effective in educating consumers about health issues. However, racial disparities exist in such advertising. In 2009, the Food and Drug Administration (FDA) issued a report that included recommendations for enhancing the ability of DTCA to reach disadvantaged populations, including racial and ethnic minorities. Reducing Race Differences in Direct to Consumer Pharmaceutical Advertising compares the pharmaceutical advertisements placed in five popular women's magazines published prior to and following the 2009 FDA report to assess the impact of these recommendations on the content and appearance of advertisements placed in magazines of differing racial orientation. From a health policy perspective, the results are disappointing. The FDA recommendations had no impact on the frequency or content of the DTCA appearing in White-oriented versus Black-oriented magazines. In fact, far fewer drugs used to treat life-threatening conditions were advertised in Black-oriented magazines after the 2009 FDA recommendations. The book concludes that enhancing the educational and motivational value of DTCA will require more than a set of recommendations. The results shed light on the pharmaceutical industry's compliance with both hard and soft regulation. Neither federal recommendations nor industry guidelines resulted in the changes to DTCA envisioned by the FDA. Regulatory action is necessary to ensure that pharmaceutical companies develop advertising campaigns that not only promote their products, but also positively impact the health outcomes of those who read their ads.

Zusammenfassung

This book examines whether direct-to-consumer pharmaceutical advertising changed in response to recommendations made by the FDA in 2009 to enhance the informational and motivational value of advertising to be more accessible to minority populations and consequently work to reduce health disparities.

Produktdetails

Autoren Stephany de Scisciolo, Stephany Scheid De Scisciolo, Teresa L Scheid, Teresa L. Scheid
Verlag Lexington Books
 
Sprache Englisch
Produktform Fester Einband
Erschienen 31.08.2018
 
EAN 9781498574167
ISBN 978-1-4985-7416-7
Seiten 140
Thema Ratgeber > Gesundheit > Sonstiges

Kundenrezensionen

Zu diesem Artikel wurden noch keine Rezensionen verfasst. Schreibe die erste Bewertung und sei anderen Benutzern bei der Kaufentscheidung behilflich.

Schreibe eine Rezension

Top oder Flop? Schreibe deine eigene Rezension.

Für Mitteilungen an CeDe.ch kannst du das Kontaktformular benutzen.

Die mit * markierten Eingabefelder müssen zwingend ausgefüllt werden.

Mit dem Absenden dieses Formulars erklärst du dich mit unseren Datenschutzbestimmungen einverstanden.